{
    "Trade/Device Name(s)": [
        "GEM Premier 3000"
    ],
    "Submitter Information": "Instrumentation Laboratory Company",
    "510(k) Number": "K052121",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022158",
        "K992834",
        "K010520"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "KPH"
    ],
    "Summary Letter Date": "October 11, 2005",
    "Summary Letter Received Date": "October 12, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1450"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Lactic Acid Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Lactate",
        "pH",
        "pCO2",
        "pO2",
        "Na+",
        "K+",
        "Ca++",
        "Hct"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GEM Premier 3000"
    ],
    "Method(s)/Technology(ies)": [
        "Glucose Oxidase",
        "Lactic Acid analysis"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for GEM Premier 3000 portable analyzer with extended reportable ranges for glucose and lactate in whole blood.",
    "Indications for Use Summary": "Portable system for rapid quantitative measurement of whole blood parameters (pH, pCO2, pO2, Na+, K+, Ca++, Glucose, Lactate, Hct) at point of care to aid in diagnosis of acid/base status, oxygen delivery, and electrolyte/metabolite balance.",
    "fda_folder": "Clinical Chemistry"
}